Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States)

Cancer Causes and Control

Volumn 14, Issue 1, 2003, Pages 37-42

  Piyathilake, Chandrika J ^a   Henao, O ^a   Frost, A R ^b   Macaluso, M ^a   Bell, W C ^b   Johanning, G L ^a   Heimburger, D C ^a   Niveleau, A ^c   Grizzle, W E ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Lung cancer; Methylation; Race

Indexed keywords

5 METHYLCYTOSINE; DNA;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DNA METHYLATION; ETHNOLOGY; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROGNOSIS; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGING; BRONCHI; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPITHELIUM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; RESPIRATORY MUCOSA; UNITED STATES;

EID: 0037306633     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022573630082     Document Type: Article

References (27)

1. Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16: 168-174.
2. Herman JG, Baylin SB (2000) Promoter-region hypermethylation and gene silencing in human cancer. Curr Topics Microbiol Immunol 249: 35-54.
3. Piyathilake CJ, Johanning GL, Frost AR, et al. (2000) Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay. Biotechnic Histochem 75: 251-258.
4. Piyathilake CJ, Frost AR, Bell WC, et al. (2001) Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol 32: 856-862.
5. Grizzle WE, Myres RB, Manne U, Srivastava S (1998) Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M, Walaszek Z, eds. John Walker's Methods in Molecular Medicine - Tumor Marker Protocols. Towota: Humana Press, pp. 143-160.
6. Bernardino J, Roux C, Almeida A, et al. (1997) DNA hypomethylation in breast cancer: an independent parameter of tumor progression? Cancer Genet Cytogenet 97: 83-89.
7. Soares J, Pinto AE, Cunha CV, et al. (1999) Global DNA hypomethylation in breast carcinoma - correlation with prognostic factors and tumor progression. Cancer 85: 112-118.
8. Gama-Sosa MA, Slagel VA, Trewyn RW, et al. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acid Res 11: 6883-6894.
9. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M (1998) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48: 1159-1161.
10. Kliasheva RI (1990) DNA methylation in human lung tumors. Voprosy Onkologii 36: 186-189.
11. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L (1997) Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer 75: 396-402.
12. Chen H, Liu J, Merrick BA, Waalkes MP (2001) Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinogen 30: 79-87.
13. 12 deficiencies in squamous cell lung cancer are associated with global DNA hypomethylation. Nutr Cancer 37: 99-107.
14. Piyathilake CJ, Bell WC, Johanning GL, Cornwell PE, Heimburger DC, Grizzle WE (2000) The accumulation of ascorbic acid by squamous cell carcinomas of the lung and larynx is associated with global methylation of DNA. Cancer 89: 171-176.
15. Soares J, Pinto AE, Cunha CV, et al. (1999) Global DNA hypomethylation in breast carcinoma - correlation with prognostic factors and tumor progression. Cancer 85: 112-118.
16. Cravo M, Fidalgo P, Pereira AD, et al. (1994) DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 3: 473-479.
17. Cravo M, Pinto R, Fidalgo P, et al. (1996) Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut. 39: 434-438.
18. Kim YI, Giuliano A, Hatch KD, et al. (1994) Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74: 893-899.
19. Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30: 441-464.
20. Chen RZ, Pettersson U, Beard C, Jackson-Grushby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates, Nature 395: 89-92.
21. Lewis J, Bird A (1991) DNA methylation and chromatin structure. FEBS Lett 285: 155-159.
22. Feinberg AP, Vogelstein B (1983) Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 111: 47-54.
23. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
24. Baylin SB, Herman JG, Graft JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196.
25. Razin A, Cedar H (1991) DNA methylation and gene expression. Microbiol Rev 55: 451-458.
26. Weissbach A, Ward C, Bolden A (1989) Eukaryotic DNA methylation and gene expression. Current Top in Cell Regul 30: 1-21.
27. Bourke W, Milstein D, Giura R, et al. (1992) Lung cancer in young adults. Chest 102: 1723-1729.